Al-Dujaili, E. A. S. & Edwards, C. R. W. (1981) Optimisation of a direct radioimmunoassay for plasma aldosterone. Journal of Steroid Biochemistry, 14, 481–487.
Allsopp, M. N. E., Levell, M. J., Stitch, S. R. & Hullin, R. P. (1972) Aldosterone production rates in manic–depressive psychosis. British Journal of Psychiatry, 120, 399–404.
Baer, L., Glassman, A. H. & Kassin, S. (1973) Negative sodium balance in lithium carbonate toxicity. Archives of General Psychiatry, 29, 823–827.
Burrows, G. D., Davies, B. & Kincaid-Smith, P. (1978) Unique tubular lesion after lithium. The Lancet, i, 1310.
Forrest, J. N. Jr, Cohen, A. D., Torretti, J., Himmelhock, J. M. & Epstein, F. H. (1974) On the mechanisms of lithium induced diabetes insipidus in man and the rat. Journal of Clinical Investigation, 53, 1115–1123.
Georgotas, A. & Gershon, S. (1979) Lithium in manic–depressive illness: some highlights and current controversies. In Lithium Controversies and Unresolved Issues (eds Cooper, T. B., Gershon, S. & Kline, N. S.), pp. 57–84. Amsterdam: Excerpta Medica.
Gillman, M. A. & Lichtigeld, F. J. (1986) Synergism of spironolactone and lithium in mania. British Medical Journal, 292, 661–662.
Gutman, Y., Tamir, N. & Benakein, F. (1973) Effect of lithium on plasma renin activity. European Journal of Pharmacology, 24, 347–351.
Haber, E., Koerner, T., Page, L. B., Kliman, B. & Purnode, A. (1969) Application of a radioimmunoassay for angiotensin I to the physiological measurement of plasma renin activity in normal human subjects. Journal of Clinical Endocrinology and Metabolism, 33, 52–62.
Hansen, H. E., Hestbach, J., Sorensen, J. L., Norgaard, K., Heilskov, J. & Amdisen, A. (1979) Chronic interstitial nephropathy in patients on long-term lithium treatment. Quarterly Journal of Medicine, 48, 577–591.
Hendler, N. (1975) Lithium-responsive hyperaldosteronism in manic patients. Journal of Nervous and Mental Disease, 161, 49–54.
Hendler, N. (1978) Spironolactone prophylaxis in manic depressive disease. Journal of Nervous and Mental Disease, 166, 517–520.
Lazarus, J. H. (1986) Lithium and the cell. In Endocrine and Metabolic effects of Lithium (ed. Lazarus, J. H.) pp. 31–34. London: Plenum Medical Book Company.
Murphy, D. L., Goodwin, F. K. & Bunney, W. E. Jr (1969) Aldosterone and sodium response to lithium administration in man. The Lancet, ii, 458–461.
Padfield, P. L., Morton, J. J., Lindop, G. & Timbury, G. C. (1975) Lithium induced nephrogenic diabetes insipidus: changes in plasma vasopressin and angiotensin II. Clinical Endocrinology, 4, 493–500.
Pedersen, E. B., Darling, S., Kierkegaard-Hansen, A. & Amdisen, A. (1977) Plasma aldosterone during lithium treatment. Neuropsychiatry, 3, 153–159.
Rademaker, M., Lindsay, A., McLaren, J. A. & Padfield, P. L. (1987) Home monitoring of blood pressure: usefulness as a predictor of persistent hypertension. Scottish Medical Journal, 32, 16–19.
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research diagnostic criteria. Archives of General Psychiatry, 35, 773–782.
Stewart, P. M., Grieve, J., Nairn, I., Padfield, P. L. & Edwards, C. R. W. (1987) Lithium inhibits the action of fludrocortisone on the kidney. Clinical Endocrinology, 27, 63–68.
Thomsen, K., Jensen, J. & Olesen, O. (1976) Effect of prolonged lithium ingestion on the response to mineralocorticoids in rats. Journal of Pharmacological Experimental Therapy, 196, 463–468.
Transbol, I., Christiansen, C., Baastrup, P. C., Nielsen, M. D. & Giese, J. (1978) Endocrine effects of lithium. Acta Endocrinologica, 88, 619–624.
Lithium Carbonate – a Competitive Aldosterone Antagonist?
eLetters
No eLetters have been published for this article.